Insmed | INSM - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cytokinetics USD 122.52M 102.95M 2025-12
DBV Technologies USD 69.84M 33.37M 2025-09
Gilead Sciences USD 7.33B 2.19B 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Regeneron Pharmaceuticals USD 18.87B 16.36B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12